XML 44 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-based Compensation (Tables)
9 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
On May 18, 2017, the Company granted RSUs under the 2018/2019 LTIP with a grant date fair value of $13.41 that vest as follows (amounts in thousands):
 
Shares
May 18, 2018
65

May 18, 2019
65

May 18, 2020
67

Total shares granted
197

    
The following is the vesting schedule of RSUs under each respective LTIP, which vested during the nine-month period ended December 31, 2017 (shares in thousands):
 
 
2017/2018
 
2016/2017
 
2015/2016
Time-based award vested
 
198

 
186

 
113

Performance-based award vested
 

 
173

 
102


Restricted stock activity, excluding the LTIP activity discussed above, for the nine-month period ended December 31, 2017 is as follows (amounts in thousands except fair value):
 
Shares
 
Weighted-
average
Fair Value on
Grant Date
Non-vested restricted stock at March 31, 2017
1,382

 
$
4.00

Granted
608

 
17.56

Vested
(477
)
 
4.35

Forfeited
(40
)
 
6.72

Non-vested restricted stock at December 31, 2017
1,473

 
$
9.49

Schedule of the compensation expense (recovery) associated with stock-based compensation
The compensation expense associated with stock-based compensation for the quarters ended December 31, 2017 and 2016 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands):
 
Quarter Ended December 31, 2017
 
Quarter Ended December 31, 2016
 
Stock 
Options
 
Restricted 
Stock
 
LTIPs
 
Stock 
Options
 
Restricted 
Stock
 
LTIPs
Cost of sales
$

 
$
210

 
$
192

 
$
3

 
$
127

 
$
178

Selling, general and administrative expenses

 
1,262

 
490

 
4

 
379

 
402

Research and development

 
12

 
40

 

 
5

 
41

Total
$

 
$
1,484

 
$
722

 
$
7

 
$
511

 
$
621


The compensation expense associated with stock-based compensation for the nine-month periods ended December 31, 2017 and 2016 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands):
 
Nine-Month Period Ended December 31, 2017
 
Nine-Month Period Ended December 31, 2016
 
Stock 
Options
 
Restricted 
Stock
 
LTIPs
 
Stock 
Options
 
Restricted 
Stock
 
LTIPs
Cost of sales
$

 
$
549

 
$
505

 
$
21

 
$
415

 
$
557

Selling, general and administrative expenses

 
2,345

 
1,294

 
20

 
1,072

 
1,232

Research and development

 
31

 
113

 
1

 
15

 
138

Total
$

 
$
2,925

 
$
1,912

 
$
42

 
$
1,502

 
$
1,927